Product image of Lutathera (Lutetium (177lu) Oxodotreotide) supplied by GNH India

Lutathera

Active Ingredient:
Lutetium (177lu) Oxodotreotide
Origin:
EU

Lutathera (Lutetium (177lu) Oxodotreotide)

Lutathera (Lutetium (177Lu) Oxodotreotide) is an intravenous medication used for targeted therapy in specific medical conditions. This advanced treatment option is designed to deliver precise therapeutic effects.

Manufacturer / TM Owner

Advanced Accelerator Applications

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Lutathera is primarily used for targeted therapy in conditions that respond to somatostatin receptor-positive neuroendocrine tumors. It works by delivering radiation directly to the tumor cells, helping to manage and treat the condition. The medication is administered intravenously and is intended for use under medical supervision.

Side Effects

  • Lutathera may cause common side effects such as nausea, fatigue, and vomiting. Some patients may experience more severe reactions, including low blood cell counts or liver enzyme changes. It is important to discuss potential effects with a healthcare provider before starting treatment.

Precautions & Warnings

  • Lutathera should be handled with care and administered by trained healthcare professionals. Patients should be monitored regularly during treatment to manage any adverse effects. Pregnant women and individuals with certain medical conditions may need special precautions or alternative treatments.

Avoid Interactions

  • Lutathera may interact with other medications, particularly those that affect kidney function or blood cell production. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness of Lutathera.

Frequently Asked Questions

Lutathera is used for targeted therapy in conditions involving somatostatin receptor-positive neuroendocrine tumors.

Lutathera is administered intravenously by healthcare professionals in a clinical setting.

Common side effects may include nausea, fatigue, and vomiting. Severe reactions can occur and should be discussed with a healthcare provider.

Pregnant women and individuals with certain medical conditions may need to avoid Lutathera or use it with special precautions.

Yes, Lutathera may interact with medications that affect kidney function or blood cell production. Always inform healthcare providers about all current medications.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lutetium (177lu) Oxodotreotide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT